A recent study using a mouse model of high-grade serous ovarian carcinoma (HGSOC) demonstrated that tumors reprogram neutrophils to suppress T cell–mediated anti-tumor immunity by activating IRE1α [178]. The gene discussed is ERN1; the disease is neoplasm.